Trial Profile
To evaluate the safety and efficacy of dose dense chemotherapy with docetaxel, cisplatin, folinic acid and 5- fluorouracil (TCF) plus Pegfilgrastim in patients with metastatic gastric cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Pegfilgrastim
- Indications Gastric cancer
- Focus Therapeutic Use
- 23 Oct 2016 New trial record